title: [Polyoxometalates. A new class of inorganic CK2 inhibitors].
authors.forename: Renaud
authors.initials: R
authors.lastname: Prudent
authors.forename: Bernold
authors.initials: B
authors.lastname: Hasenknopf
authors.forename: Claude
authors.initials: C
authors.lastname: Cochet
mesh_terms: D000255:Adenosine Triphosphate / Q000502:physiology; D000818:Animals; D000838:Anions / Q000737:chemistry / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D001665:Binding Sites / Q000187:drug effects; D001667:Binding, Competitive; D047390:Casein Kinase II / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000502:physiology; D020134:Catalytic Domain / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D020650:Combinatorial Chemistry Techniques; D006801:Humans; D053768:Metal Nanoparticles / Q000737:chemistry* / Q000627:therapeutic use; D051379:Mice; D008958:Models, Molecular; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology; D017601:Oxygen Compounds / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D028561:Transition Elements / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D023041:Xenograft Model Antitumor Assays
chemical_list: D000838:Anions; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D017601:Oxygen Compounds; D047428:Protein Kinase Inhibitors; D028561:Transition Elements; D000255:Adenosine Triphosphate; D047390:Casein Kinase II